Intravenous administration of granulocyte colony-stimulating factor for treating neuropathic pain associated with compression myelopathy: A phase i and IIa clinical trial

European Spine Journal

Volumn 22, Issue 1, 2013, Pages 197-204

  Kato, Kei ^a   Yamazaki, Masashi ^a   Okawa, Akihiko ^a   Furuya, Takeo ^a   Sakuma, Tsuyoshi ^a   Takahashi, Hiroshi ^a   Kamiya, Koshiro ^a   Inada, Taigo ^a   Takahashi, Kazuhisa ^a   Koda, Masao ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Clinical trial; Granulocyte colony stimulating factor; Myelopathy; Neuropathic pain; Neuroprotective therapy

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; BONE PAIN; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; JAPANESE ORTHOPAEDIC ASSOCIATION SCORE; LEUKOCYTE COUNT; LIGAMENTUM FLAVUM; LIVER DYSFUNCTION; MALE; NEUROPATHIC PAIN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPINAL CORD DECOMPRESSION; SPINAL CORD DISEASE; VISUAL ANALOG SCALE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEURALGIA; PAIN MEASUREMENT; SPINAL CORD COMPRESSION;

EID: 84872413335     PISSN: 09406719     EISSN: 14320932     Source Type: Journal    
DOI: 10.1007/s00586-012-2556-9     Document Type: Article

References (22)

1. Baastrup C, Finnerup NB (2008) Pharmacological management of neuropathic pain following spinal cord injury. CNS Drugs 22:455-475
2. Cardenas DD, Warms CA, Turner JA et al (2002) Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trial. Pain 96:365-373
3. Gibson CL, Jones NC, Prior MJ et al (2005) G-CSF suppresses edema formation and reduces interleukin-1β expression after cerebral ischemia in mice. J Cereb Blood Flow Metab 25:431-439
4. Kawabe J, Koda M, Hashimoto M et al (2011) Granulocyte colony-stimulating factor (G-CSF) exerts neuroprotective effects via promoting angiogenesis after spinal cord injury in rats. J Neurosurg Spine 15:414-421
5. Kawada H, Takizawa S, Takanashi T et al (2006) Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells. Circulation 113:701-710
6. Koda M, Nishio Y, Kamada T et al (2007) Granulocyte colony-stimulating factor (G-CSF) mobilizes bone marrow-derived cells into injured spinal cord and promotes functional recovery after compression-induced spinal cord injury in mice. Brain Res 1149:223-231
7. Komine-Kobayashi M, Zhang N et al (2006) Neuroprotective effect of recombinant human granulocyte colony-stimulating factor in transient focal ischemia of mice. J Cereb Blood Flow Metab 26:402-413
8. Levendoglu F, Ogün CO, Ozerbil O et al (2004) Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury. Spine 29:743-751
9. Masaki Y, Yamazaki M, Okawa A et al (2007) An analysis of factors causing poor surgical outcome in patients with cervical myelopathy due to ossification of the posterior longitudinal ligament: anterior decompression with spinal fusion versus laminoplasty. J Spinal Disord Tech 20:7-13
10. New PW, Lim TC, Hill ST et al (2007) A survey of pain during rehabilitation after acute spinal cord injury. Spinal Cord 35:658-663
11. Nicola NA, Metcalf D, Matsumoto M et al (1983) Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Identification as granulocyte colony-stimulating factor. J Biol Chem 258:9017-9023
12. Nishio Y, Koda M, Kamada T et al (2007) Granulocyte colony-stimulating factor attenuates neuronal death and promotes functional recovery after spinal cord injury in mice. J Neuropathol Exp Neurol 66:724-731
13. Petersen GL, Finnerup NB, Nørskov KN et al (2012) Placebo manipulations reduce hyperalgesia in neuropathic pain. Pain 153:1292-1300
14. Rintala DH, Holmes SA, Courtade D et al (2007) Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury. Arch Phys Med Rehabil 88:1547-1560
15. Ro LS, Chen SR, Chao PK et al (2009) The potential application of granulocyte colony stimulating factor therapy on neuropathic pain. Chang Gung Med J 32:235-246
16. Roberts AW (2005) G-CSF: a key regulator of neutrophil production, but that's not all! Growth Factors 23:33-41
17. Sakuma T, Yamazaki M, Okawa A et al (2011) Neuroprotective therapy using granulocyte-colony stimulating factor for patients with worsening symptoms of compression myelopathy, part 1: a phase I and IIa clinical trial. Eur Spine J 21:482-489
18. Schäbitz WR, Kollmar R, Schwaninger M et al (2003) Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 34:745-751
19. Schneider A, Kuhn HG, Schäbitz WR (2005) A role for G-CSF (granulocyte-colony stimulating factor) in the central nervous system. Cell Cycle 4:1753-1757
20. Siddall PJ, Cousins MJ, Otte A et al (2006) Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial. Neurology 67:1792-1800
21. Störmer S, Gerner HJ, Grüninger W et al (2007) Chronic pain/dysaesthesiae in spinal cord injury patients: results of a multicentre study. Spinal Cord 35:446-455
22. Yamazaki M, Sakuma T, Kato K et al (2012) Granulocyte colony-stimulating factor reduced neuropathic pain associated with thoracic compression myelopathy: report of 2 cases. J Spinal Cord Med (in press)